http://www.mmc.org/prostate-gu-cancer - When Bill was diagnosed with prostate cancer, he had several treatment options. The choice was up to him, but Bill was shaken by the cancer diagnosis, scared, and not sure how he could make the right decision. He was relieved when he found help at Maine Medical Center, particularly from a patient navigator who supported him throughout his cancer journey.

VIDEO TRANSCRIPT:


BILL ROYALL: I'm a stone carver, and I make jewelry.

These are the Tetons, where we spend the winter.

I skied one hundred and three days last winter.

I have, you know, a lot of different things I do. I have an active life.

We had to go in and talk to the doctor.

He said, "Well, you've got cancer."

It's scary.

And it's hard to make good, solid, decisions, when you're scared.

There were people there that, helped us learn,

and again the Nurse Navigators, were priceless.

TRACY ROBBINS: So as a Nurse Navigator, my role is to really help them

understand their diagnosis and their treatment options.

Patients are referred to me at their initial diagnosis. It's brand new for them, so a lot of them are pretty anxious.

When they just want to know what's going to happen to them.

Most prostate cancer patients have options.

Whether it be active surveillance, or active treatment.

They could have surgery, they could have radiation.

DR. IAN BRISTOL: It's very important for patients who have options,

to go into any treatment with a very full understanding.

I see my major role as a physician, to provide patients with an education.

DR. MATTHEW HAYN: The tumor conference at Maine Medical Center is a great resource.

We have surgeons, radiation oncologists, medical oncologists, and our nurse navigator

all participating in a discussion about each individual patient and the best course of treatment.

The navigator within the tumor conference can be the voice of the patient

and can really advocate for the patient's best interest.

TRACY: I enjoying working with patients and providing them with an education,

and really being part of their cancer journey with them.

And they know they can call me at any time.

From their initial diagnosis through active treatment, into survivorship.

EMERY ROYAL: It was wonderful to be able to be there.

BILL: I was amazed how smoothly, and how graceful, the whole process was.

I know I went to the right place and had the right thing done.

I ended up making the best decision for me.

It fit me, fit my body, fit the family.

It's not easy.

But we had a lot of help.

I had a spouse, nurse navigators, had Maine Med, you know.

It was good.

I'm here. I've lived to tell about it.

(OFF CAMERA): Here comes Billy Boy!

BILL: Yahoo!

Prostate cancer is the second most common cancer in men. But the ratio between diagnosis and death from the disease is worth thinking about. Prostate cancer is a deadly disease - so much is true - with roughly 34,000 deaths in the US alone. But far from all men with that diagnosis die from prostate cancer. The problem is that the natural course of the disease is not completely understood. While some men are in danger of dying from it, others are not. Since science hasn't completely figured out how to identify those who are at risk and pick them for according treatment. This results in unnecessary diagnosis and treatment, which remain a real problem in the handling of prostate cancer. Dr. med. dr. phil. Stefan Buntrock, urologist from Göttingen, explains in this video on UroChannel the problems linked to the PSA (prostate specific antigen) test. PSA dynamics and multiparametric MRI are tools to help reduce overdetection and overtreatment. Multiparametric MRI has been around for about 15 years and is about to become standard of care soon. Overdiagnosis and overtreatment is a "must know" for every man since a simple blood test may have a profound impact upon the individual's life.

HOMEPAGE:
https://www.buntrock-urologie.de/

SOCIAL MEDIA:
https://www.instagram.com/urochannel/

CHECK OUT GOLF_MD ON YOUTUBE FOR GOLF FITNESS AND MEDICAL TOPICS ON GOLF!
https://www.youtube.com/channe....l/UC5eWWnOXx6nFacy5n

#prostatecancer #overdiagnosis #overtreatment

Medical oncologist Mark Scholz, MD, fields questions all about TULSA-PRO, an image-guided form of high-intensity focused ultrasound that is becoming more popular as a form of focal therapy for prostate cancer. The hope is that this procedure can reduce the side effects of radical treatment via surgery or radiation while maintaining excellent cure rates.

0:09 What are HIFU and TULSA-PRO and how do they work?

2:13 What are the side effects of these treatments?

4:33 At what point would a prostate be too large for treatment with HIFU or TULSA-PRO?

5:40 Is HIFU more or less effective depending on the Gleason score?

6:41 If a patient with a high Gleason score has HIFU, should they also have a course of hormone therapy?

8:07 Are HIFU and TULSA-PRO considered curative therapies?

8:31 How do TULSA-PRO and HIFU compare to other forms of focal therapy?

10:03 Are these treatments covered by Medicare or other insurances?

10:31 Which factors would you take into consideration if deciding between HIFU or TULSA-PRO?

11:22 How many procedures would you expect a doctor to have performed to be considered competent in HI-FU or TULSA-PRO?

12:32 What should PSA look like after focal therapy with HI-FU or TULSA-PRO?

Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org

To learn more about prostate cancer visit http://www.pcri.org

Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.

The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.

#ProstateCancer #Prostate #MarkScholzMD

This video includes British Sign Language interpretation. In this cancer information video, Urologist Shiv Bhanot describes the symptoms of prostate cancer and explains the PSA test (prostate-specific antigen test). Patrick, who is living with prostate cancer, talks about going to his GP after having symptoms and how the condition affects black males more than others.

For more information about prostate cancer, visit: https://www.macmillan.org.uk/c....ancer-information-an

Join our prostate cancer forum to support one another, ask questions and share experiences: https://community.macmillan.or....g.uk/cancer_types/pr

Subscribe to our YouTube channel: http://bit.ly/UsAbto
Twitter: https://twitter.com/macmillancancer
Facebook: https://www.facebook.com/macmillancancer
Instagram: https://www.instagram.com/macmillancancer

Mark Moyad, MD, MPH discusses testosterone replacement after prostate cancer treatment with expert, Stephen Auerbach, MD.

Dr. Stephen Auerbach: https://www.hoag.org/find-a-do....ctor/a/stephen-m-aue


The Prostate Cancer Research Institute is a 501(c)(3) Non-Profit Organization that educates prostate cancer patients and caregivers about prostate cancer. Visit our website www.pcri.org.

Donate at www.pcri.org/donate

The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.

#ProstateCancer #MarkMoyadMD #StephenAuerbachMD

PCRI's CEO, Alex Scholz, asks medical oncologist, Mark Scholz, MD, about hormone therapy alongside radiation therapy for men with Gleason 4+4=8 prostate cancer.

0:05 Why is hormone therapy beneficial for men undergoing radiation for Gleason 8?

1:38 What hormone therapies are used for Gleason 4+4=8?

2:52 Do most oncologists prescribe a second-generation hormonal agent as an initial treatment?

4:04 Does hormone therapy happen before or after radiation?

5:08 Typically, what types of radiation are used for Gleason 4+4=8?

5:40 What should a patient's PSA be after treatment and in what time frame?

6:54 How long do PSA bumps last?

7:16 How often do men need to have scans during a PSA bump?

Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org

To learn more about prostate cancer visit http://www.pcri.org

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.

The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.

#ProstateCancer #Prostate #MarkScholzMD

PCRI's Alex and Executive Director, Mark Scholz, MD, discuss the most searched question on prostate cancer: "How does one avoid getting prostate cancer?"

Don’t know your prostate cancer stage? Take the quiz: Visit http://www.prostatecancerstaging.org
To learn more about prostate cancer visit http://www.pcri.org

To download the free Staging Guide visit http://www.pcri.org/prostate-cancer-s...

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.

The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.

#ProstateCancer #Prostate #MarkScholzMD

In the United States, prostate cancer occurs more frequently in African-American men and more often results in mortality when compared to the general population. While the reasons are not yet totally understood, Alex and Mark Scholz, MD, discuss what practical steps African-American men can take to lower their risk of dying from prostate cancer.

0:11 How is the screening process different for African-American men?

1:12 Why do African-American men need to start PSA testing earlier?

2:05 Why do African-American men seem to have higher initial PSA results?

2:38 Is the active surveillance process different for African-American men?

3:37 Why are certain drugs more effective for African-American men than men in general?

4:46 Are Xtandi and other hormone therapies usually more effective in African-American men?

5:12 How does age affect the risk factor for developing prostate cancer in African-American men?

5:48 What is the best way to spread awareness of these risk factors?

Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org

To learn more about prostate cancer visit http://www.pcri.org

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.

The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.

#ProstateCancer #Prostate #MarkScholzMD